C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/16 (2006.01) A61K 31/47 (2006.01) C07B 59/00 (2006.01) C07D 215/22 (2006.01)
Patent
CA 2156389
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions and inducing anesthesia are disclosed by administering to an amimal in need of such treatment a substituted or unsubstituted 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-one or pharmaceutically acceptable salts thereof which have high binding to the glycine receptor
Cai Sui Xiong
Keana John F. W.
Weber Eckard
Cai Sui Xiong
Keana John F. W.
Mbm & Co.
Oregon State Of Oregon Acting By And Through The Oregon State Board Of
The Regents Of The University Of California
LandOfFree
4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-hydroxy-3-nitro-1,2-dihydroquinolin-2-ones and the use... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1451448